As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...

As Hurricane Milton made landfall in Florida Wednesday night, drugmakers, regulators, hospitals and health agencies alike ...

As Novo Holdings hopes to close its $16.5 billion acquisition of CDMO Catalent by the end of the year, the deal is facing a fresh round of lawmaker scrutiny. | In a letter to the chair of the U.S.

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

With an FDA decision looming over its first foray into the acute pain space, Vertex Pharmaceuticals has commissioned a pair ...

In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...

Two years after raiding the offices of Novartis, Switzerland’s Competition Commission (COMCO) has dropped its investigation ...

Symbiosis Pharmaceutical Services has shelled out £1.2 million ($1.57 million) to acquire a new manufacturing building at ...

Zevra Therapeutics has partnered with the National Urea Cycle Disorders Foundation to run an awareness campaign designed to ...